Compounds > sr141716
Page last updated: 2024-08-26

sr141716 and Mood Disorders

sr141716 has been researched along with Mood Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butler, P; Munafò, MR; Nutt, DJ; Robinson, ES; Stuart, SA1
Bambico, FR; Cassano, T; Dominguez-Lopez, S; Gobbi, G; Katz, N; Piomelli, D; Walker, CD1
Christopoulou, FD; Kiortsis, DN1
Formiguera, X; Scheen, AJ; Van Gaal, LF1

Reviews

1 review(s) available for sr141716 and Mood Disorders

ArticleYear
An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity.
    Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1

    Topics: Anti-Obesity Agents; Humans; Molecular Targeted Therapy; Mood Disorders; Obesity; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Receptor, Cannabinoid, CB1; Rimonabant

2011

Other Studies

3 other study(ies) available for sr141716 and Mood Disorders

ArticleYear
Distinct Neuropsychological Mechanisms May Explain Delayed- Versus Rapid-Onset Antidepressant Efficacy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:9

    Topics: Animals; Antidepressive Agents; Association Learning; Brain; Cannabinoid Receptor Antagonists; Carbolines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; GABA Antagonists; Ketamine; Male; Mood Disorders; Piperidines; Pyrazoles; Rats; Reaction Time; Reinforcement, Psychology; Rimonabant; Stress, Psychological; Venlafaxine Hydrochloride

2015
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:10

    Topics: Action Potentials; Amidohydrolases; Animals; Behavior, Animal; Benzamides; Brain; Cannabinoid Receptor Antagonists; Carbamates; Enzyme Inhibitors; Exploratory Behavior; Hindlimb Suspension; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Mood Disorders; Piperidines; Prefrontal Cortex; Pyrazoles; Raphe Nuclei; Rimonabant; Serotonin; Serotonin Agents; Swimming

2010
The safety of obesity drugs.
    Expert opinion on drug safety, 2007, Volume: 6, Issue:5

    Topics: Appetite Depressants; Humans; Mood Disorders; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2007